Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing with over $20 Million Dollars

prnasiaMarch 23, 2021

Tag: Tavotek , YuanBio , Oriza Holdings , Ming Bioventures , New Alliance Capital

PharmaSources Customer Service